You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 17, May 1, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the Clinical Center of the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chemoprevention of Breast Cancer

Joyce A. O'Shaughnessy, MD

JAMA. 1996;275(17):1349-1353.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CASE REPORT

A 46-year-old woman was found on mammography to have a solid 1-cm mass in her right breast. Excisional biopsy identified a fibroadenoma, and 3 foci of cribriform ductal carcinoma in situ (DCIS) with necrosis were incidentally noted, in addition to areas of lobular neoplasia and atypical ductal hyperplasia (ADH). The surgical margins were clear of DCIS, and her right breast was treated with radiotherapy. This patient's 50-year-old sister had recently been diagnosed with breast cancer. With lobular and ductal neoplasia placing this patient at increased risk of developing breast cancer in her other breast, the patient questioned her physicians regarding the appropriateness of her taking tamoxifen as a chemopreventive agent and whether any genetic studies could be done on her breast tissue to more accurately predict the risk of her developing a second malignancy.

The biopsy showed that this woman is at high risk for developing breast cancer . . . [Full Text PDF of this Article]


Author Affiliations

From the Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md.


Footnotes

Reprints: Joyce A. O'Shaughnessy, MD, Medicine Branch, National Cancer Institute, Bldg 10, Room 12N226, Bethesda, MD 20892.

Grand Rounds at the Clinical Center of the National Institutes of Health section editors: John I. Gallin, MD, the Clinical Center of the National Institutes of Health, Bethesda, Md; David S. Cooper, MD, Contributing Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.